Benzinga | Mar 11, 2021 04:04PM EST

Kezar Life Sciences Q4 EPS $(0.22) Up From $(0.50) YoY

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.22) per share. This is a 56 percent increase over losses of $(0.50) per share from the same period last year.